Overview
- 90 inspections across 88 sites are on record.
- 216 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2026-05-08.
At a glance
Inspections
90
Sites
88
Observations
216
Career since
Sep 2012
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Qilu Pharmaceutical Co., Ltd. (Biological Industrial Park) | 8 May 2026 | Human Drugs | On file |
| Zhejiang Huahai Pharmaceutical Co., Ltd. | 24 Apr 2026 | Human Drugs | On file |
| Reliance Life Sciences Private Limited | 27 Feb 2026 | Human Drugs | On file |
| Alembic Pharmaceuticals Limited | 18 Feb 2026 | Human Drugs | On file |
| Huons Co., Ltd. | 21 Nov 2025 | Human Drugs | On file |
Sites inspected
Qilu Pharmaceutical Co., Ltd. (Biological Industrial Park)Jinan, China1 insp.
Zhejiang Huahai Pharmaceutical Co., Ltd.Linhai, China1 insp.
Reliance Life Sciences Private LimitedNavi Mumbai, India1 insp.
Alembic Pharmaceuticals LimitedVadodara, India1 insp.
Huons Co., Ltd.Jecheon, Korea (the Republic of)1 insp.
Co-investigators
Investigators who share inspections with this person.
Ashar P Parikh9 shared
Kham Phommachanh5 shared
Burnell M Henry4 shared
Rumany C Penn4 shared
Joseph A Piechocki3 shared
Rajiv R Srivastava3 shared
Linda Thai3 shared
Prabhu P Raju3 shared
Debra M Emerson3 shared
Marcellinus D Dordunoo2 shared
Full investigator report
Get the verbatim findings behind Eileen A Liu's 216 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site